Learn how we collaborated with Alexion Pharmaceuticals to develop a QSP model to assess a Lipid Nanoparticle to tre… https://t.co/oyjpVj8WHV
Interested in learning more about mathematical modeling in drug R&D? Join us at our upcoming QSP Summit - a virtual… https://t.co/gfQmPdcMUE
Quantitative Systems Pharmacology approaches can be leveraged to provide guidance in your drug discovery and develo… https://t.co/QkdoukQqhw
Call for abstracts! Poster prizes awarded to the top three students or postdoc posters. Register or submit an abstr… https://t.co/icjrbMcxYL
We are accepting abstracts from all undergraduate, graduate, postdoctoral, industry (biotechs and pharma), faculty… https://t.co/Pq7cqrFg7e
We are excited to announce that our collaboration with KSQ Therapeutics was recently published in the journal, CPT:… https://t.co/tPF6fORhlP
We are excited to announce that Revitope Oncology is extending its collaboration to develop a systems pharmacology… https://t.co/GLWnzxA6Tj
Our fourth annual QSP Summit is taking place tomorrow, virtually, from 9 a.m. - 5 p.m. ET. See what all we have planned and register at: https:// www.appliedbioma th.com/ quantitative-sys tems-pharmacolo gy-summit-2020
We are excited to announce our two-year strategic partnership with Xencor! View our press release to learn more about the partnership at: https:// www.appliedbioma th.com/ news-resources/ news/ applied-biomath- llc-announces-t wo-year-strateg ic-partnership- xencor-inc
Applied BioMath is creating a systems pharmacology model to support fibrinolytic therapy for refractory COVID-19 Acute Respiratory Distress Syndrome. The recent publication, "Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review," provides...
Similar Businesses
